High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

Can Medical Evidence Be Trusted Without Scrutiny?

Published findings may be affected by methodological issues, reporting choices, and financial interests, highlighting the need for clinicians to carefully assess the evidence.

When to Screen Older Patients for Valve Disease?

Some experts are encouraging patients older than 65 years to get screened for heart valve failure, even as research lags on the benefits of population screening programs.

GLP-1 Therapy and OSA: Promise, But Limits

Tirzepatide improves apnea severity and weight in SURMOUNT-OSA, but experts say many patients still have residual disease and long-term data are needed.

Biomarkers May Help Predict PAP Benefit in Sleep Apnea

Two biomarkers, hypoxic burden and heart rate response, may help identify patients with obstructive sleep apnea who may derive greater cardiovascular benefits from long-term PAP therapy.

Childhood Reasoning Tied to Lower Later-Life Dementia Risk

Higher childhood inductive reasoning ability is associated with a lower risk for dementia decades later.

Tampons Have Traces of Lead: Does it Matter?

While levels of lead released from tampons are low, the amount absorbed into the body and its effects on health are unclear.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

Published findings may be affected by methodological issues, reporting choices, and financial interests, highlighting the need for clinicians to carefully assess the evidence.

Some experts are encouraging patients older than 65 years to get screened for heart valve failure, even as research lags on the benefits of population screening programs.

Tirzepatide improves apnea severity and weight in SURMOUNT-OSA, but experts say many patients still have residual disease and long-term data are needed.

Two biomarkers, hypoxic burden and heart rate response, may help identify patients with obstructive sleep apnea who may derive greater cardiovascular benefits from long-term PAP therapy.

Higher childhood inductive reasoning ability is associated with a lower risk for dementia decades later.

While levels of lead released from tampons are low, the amount absorbed into the body and its effects on health are unclear.

News All Time

The Dark Side of Full Patient Autonomy

Amid the backlash against paternalism and efforts to rebuild trust, an important ethical principle got caught in the fallout: the duty to act in the patient’s best interest.

CDK4/6 Inhibitors: One Class, Three Outcomes

Abemaciclib and ribociclib now show adjuvant survival benefit; palbociclib didn't. Laura Spring, MD, on picking the right agent per patient.

JAK Inhibitors Linked to Reduced Disease Activity in RA

JAK inhibitors are linked to reduced disease activity and improved patient-reported outcomes in patients with rheumatoid arthritis, regardless of diabetes, cardiometabolic burden, or age.

IL-6 May Predict HF Risk in Adults With Obesity and Diabetes

Higher interleukin 6 concentrations are linked to an increased risk for heart failure in adults with type 2 diabetes and overweight or obesity.

Global Definition Breaks MI Into Three Clinical Categories

A new global definition of myocardial infarction will allow cardiologists and other healthcare professionals to improve diagnosis and treatment of patients with the disorder.

‘I Had to Choose’: When Your Medical Career Isn’t Fulfilling

For physicians, a fulfilling career often starts with unlearning the habits that made them successful in medicine — and finding the courage to try.

Normothermia After Cardiac Arrest Tied to Improved Survival

A near-normal peak temperature after in-hospital cardiac arrest is linked to higher survival rates than lower or higher temperature ranges.

Inappropriate Prescribing Cascades Put Older Adults at Risk

Drugs used commonly in older adults can cause side effects that trigger cascades of new prescriptions, potentially causing harm.

High or Low Testosterone May Raise Atrial Fibrillation Risk

A narrative review of the link between testosterone levels and atrial fibrillation in men suggests a U-shaped relationship; however, more research is needed.

Intense Septal LGE on Cardiac MRI Flags Cardiac Amyloidosis

Intense late gadolinium enhancement of the interatrial septum on cardiac MRI offers a highly specific marker to differentiate cardiac amyloidosis from other cardiomyopathies.

Muscle Loss on GLP-1s: Data and Debate

Muscle loss during GLP-1 therapy sparked a lively debate at the 2026 ADA Scientific Sessions. Here's what the data show, who's at risk, and how to counsel patients.

Where You Live May Shape Sleep Apnea Outcomes

Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events.

CGM Looks Perfect. A1c Doesn't. Which One Is Right?

CGM and A1c increasingly disagree, especially with AID pumps. When should clinicians trust time in range over A1c? The evidence, the guideline gaps, and access disparities in type 1 and 2 diabetes.

Stroke Risk Peaks in the 3 Months After Cancer Diagnosis

The magnitude of the risk varies widely by cancer type, being highest for patients with lung or pancreatic cancers.

Routine Liver Markers May Signal Future Cardiovascular Risk

Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline.

Functional Angio Wins in Multivessel STEMI

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.

Recommended News For You

Treating advanced prostate cancer

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

Dissociative identity disorder: method or fact?

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

Recommended Articles For You

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Introduction to Immune Thrombocytopenic Purpura 

Extracellular Vesicle Markers of Platelet Activation: Clinical Relevance and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New guidelines for radiation therapy for HPV-associated head and neck cancer

2.

Cancer mortality continuing to decline, says report

3.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

4.

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

5.

Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

1.

Different Types of Blood Dyscrasias 

2.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

3.

Lymphomatoid Papulosis: What You Need to Know

4.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

5.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Clinical Insights in Oncology

2.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Navigating the Complexities of Ph Negative ALL - Part XI

5.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot